News & Updates

Doxorubicin, hypertension predict lower breast cancer recurrence
Doxorubicin, hypertension predict lower breast cancer recurrence
21 Aug 2023 byStephen Padilla

Certain comorbidities such as hypertension and diabetes mellitus (DM), along with locally advanced stage at diagnosis and systemic treatment received (ie, doxorubicin), are significantly associated with tumour recurrences among patients with breast cancer, according to a study presented at the recent ASCO Breakthrough 2023.

Doxorubicin, hypertension predict lower breast cancer recurrence
21 Aug 2023
Targeted approaches for T2D prevention, treatment needed for different Asian ethnic groups
Targeted approaches for T2D prevention, treatment needed for different Asian ethnic groups
19 Aug 2023
OGTT-based model predicts GDM in pregnant women
OGTT-based model predicts GDM in pregnant women
18 Aug 2023

The current diagnostic criteria being used to predict gestational diabetes mellitus (GDM) is not fully reliable, but adding oral glucose tolerance test (OGTT) to the model may improve early prediction of GDM, according to a study.

OGTT-based model predicts GDM in pregnant women
18 Aug 2023
Metabolic syndrome carries increased risk of lung cancer
Metabolic syndrome carries increased risk of lung cancer
15 Aug 2023

Individuals with metabolic syndrome (MetS) have a heightened risk of incident lung cancer, with the risk increase especially pronounced in those with a higher number of metabolic abnormalities and in women, according to a study.

Metabolic syndrome carries increased risk of lung cancer
15 Aug 2023